company

NORSK BIOVARME AS

2615 LILLEHAMMER

Return on Equity
−5,62 %
Current Ratio
1,09
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue1 900 000
Net Income−5 000
Total Assets978 000
Total Equity89 000
Income (NOK)2022
Revenue1 900 000
Expenditure1 865 000
Operating Profit35 000
Financial Income2 000
Financial Costs43 000
Financial Balance−41 000
Earnings Before Tax−6 000
Tax−1 000
Net Income−5 000
Balance (NOK)2022
Total Fixed Assets8 000
Total Current Assets970 000
Total Assets978 000
Total Retained Equity59 000
Total Equity89 000
Total Long-Term Debt0
Total Current Debt889 000
Total Equity and Debt978 000
Cash flow (NOK)2022
Sales Income1 900 000
Other Income0
Revenue1 900 000
Cost of Goods Sold794 000
Salary Costs551 000
Depreciation9 000
Impairment0
Expenditure1 865 000
Operating Profit35 000
Financial Income2 000
Financial Costs43 000
Financial Balance−41 000
Dividends0
Net Income−5 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets4 000
Real Eastate0
Machinery and Plant Facilities0
Fixtures5 000
Total Tangible Assets5 000
Total Fiancial Fixed Assets0
Total Fixed Assets8 000
Stock863 000
Total Investments0
Cash, Bank0
Total Current Assets970 000
Total Assets978 000
Total Equity89 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors215 000
Unpaid Taxes265 000
Dividends0
Other Current Debt83 000
Total Current Debt889 000
Total Equity and Debt978 000
Financial indicators2022
Return on Equity−5,62 %
Debt-to-Equity Ratio0
Operating Profit Margin1,84 %
Current Ratio1,09
Quick Ratio37,31
Equity Ratio0,09
Gross Profit Margin58,21 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English